calcitonin receptor |
AMRINONE |
Calcitonin |
-20% |
NoneNone |
NoneNone |
View
|
chemokine (C-C motif) receptor 5 |
AMRINONE |
Chemokine CCR5 |
-20% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 1 |
URETHANE |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|
adenosine A2a receptor |
NEOMYCIN |
Adenosine A2A |
-20% |
NoneNone |
NoneNone |
View
|
chemokine (C-C motif) receptor 5 |
NEOMYCIN |
Chemokine CCR5 |
-20% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-1A2 monooxygenase |
AMPICILLIN |
CYP450-1A2 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
leukotriene C4 synthase |
ACONITINE |
Leukotriene C4 Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
leukotriene C4 synthase |
ACONITINE |
Leukotriene C4 Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
ETHACRYNIC ACID |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
ETHACRYNIC ACID |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
DNA encoding receptor of vasoactive intestinal polypeptide |
AMIKACIN |
Vasoactive Intestinal Peptide VIP1 |
-20% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-1A2 monooxygenase |
EUCALYPTOL |
CYP450-1A2 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, beta 3 |
ETHACRYNIC ACID |
Adrenergic beta3 |
-20% |
NoneNone |
NoneNone |
View
|
synaptic vesicle glycoprotein 2b |
COLISTIN |
beta-Lactamase |
-20% |
NoneNone |
NoneNone |
View
|
protein kinase C, alpha |
THALIDOMIDE |
Protein Serine/Threonine Kinase PKCalpha |
-20% |
NoneNone |
NoneNone |
View
|
protein kinase C, alpha |
THALIDOMIDE |
Protein Serine/Threonine Kinase PKCalpha |
-20% |
NoneNone |
NoneNone |
View
|
platelet-activating factor receptor |
PRIMIDONE |
Platelet Activating Factor (PAF) |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
CINNAMALDEHYDE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
CINNAMALDEHYDE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, beta 3 |
BENZYL ALCOHOL |
Adrenergic beta3 |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
CIMETIDINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
CIMETIDINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
CIMETIDINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
CIMETIDINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
CIMETIDINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
CIMETIDINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
CIMETIDINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
CIMETIDINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
CIMETIDINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 14 |
SULINDAC |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
synaptic vesicle glycoprotein 2b |
CHLORPROMAZINE |
beta-Lactamase |
-20% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor 2 |
CHLORPROMAZINE |
Leukotriene B4 |
-20% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor |
CHLORPROMAZINE |
Leukotriene B4 |
-20% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor |
CHLORPROMAZINE |
Leukotriene B4 |
-20% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor 2 |
CHLORPROMAZINE |
Leukotriene B4 |
-20% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 1 |
CHLOROXYLENOL |
Muscarinic M1 |
-20% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 2 |
CHLOROXYLENOL |
Muscarinic M2 |
-20% |
NoneNone |
NoneNone |
View
|
DNA encoding receptor of vasoactive intestinal polypeptide |
CHLOROXYLENOL |
Vasoactive Intestinal Peptide VIP1 |
-20% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 1d (Non-specific probe) |
CHLORAMPHENICOL |
Adrenergic alpha1D |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
STANNOUS FLUORIDE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
STANNOUS FLUORIDE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
STANNOUS FLUORIDE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
STANNOUS FLUORIDE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
STANNOUS FLUORIDE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
STANNOUS FLUORIDE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
STANNOUS FLUORIDE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
STANNOUS FLUORIDE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
STANNOUS FLUORIDE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
STANNOUS FLUORIDE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
STANNOUS FLUORIDE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
STANNOUS FLUORIDE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
STANNOUS FLUORIDE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
STANNOUS FLUORIDE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
STANNOUS FLUORIDE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
STANNOUS FLUORIDE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
STANNOUS FLUORIDE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
synaptic vesicle glycoprotein 2b |
TACROLIMUS |
beta-Lactamase |
-20% |
NoneNone |
NoneNone |
View
|
cannabinoid receptor 1 (brain) |
STANNOUS FLUORIDE |
Cannabinoid CB1 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
TACROLIMUS |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
TACROLIMUS |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
chemokine (C-C motif) receptor 5 |
AMLODIPINE |
Chemokine CCR5 |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
AMINOGLUTETHIMIDE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
AMINOGLUTETHIMIDE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
AMINOGLUTETHIMIDE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
AMINOGLUTETHIMIDE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
AMINOGLUTETHIMIDE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
AMINOGLUTETHIMIDE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
AMINOGLUTETHIMIDE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
AMINOGLUTETHIMIDE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
AMINOGLUTETHIMIDE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
AMINOGLUTETHIMIDE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
AMINOGLUTETHIMIDE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
AMINOGLUTETHIMIDE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
AMINOGLUTETHIMIDE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
AMINOGLUTETHIMIDE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
AMINOGLUTETHIMIDE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
AMINOGLUTETHIMIDE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
AMINOGLUTETHIMIDE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
BETA-ESTRADIOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
BETA-ESTRADIOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
BETA-ESTRADIOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
BETA-ESTRADIOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
BETA-ESTRADIOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
BETA-ESTRADIOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
BETA-ESTRADIOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
BETA-ESTRADIOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
BETA-ESTRADIOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
BETA-ESTRADIOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
BETA-ESTRADIOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
BETA-ESTRADIOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
BETA-ESTRADIOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
BETA-ESTRADIOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
platelet derived growth factor receptor, alpha polypeptide |
ETHINYLESTRADIOL |
Platelet-Derived Growth Factor (PDGF) |
-20% |
NoneNone |
NoneNone |
View
|
platelet-derived growth factor receptor, alpha polypeptide |
ETHINYLESTRADIOL |
Platelet-Derived Growth Factor (PDGF) |
-20% |
NoneNone |
NoneNone |
View
|
platelet derived growth factor receptor, beta polypeptide |
ETHINYLESTRADIOL |
Platelet-Derived Growth Factor (PDGF) |
-20% |
NoneNone |
NoneNone |
View
|
platelet-derived growth factor receptor, beta polypeptide |
ETHINYLESTRADIOL |
Platelet-Derived Growth Factor (PDGF) |
-20% |
NoneNone |
NoneNone |
View
|
angiotensin 1 converting enzyme 1 |
FLUTAMIDE |
Protease, Angiotensin Converting Enzyme |
-20% |
NoneNone |
NoneNone |
View
|
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
FLUTAMIDE |
Protease, Angiotensin Converting Enzyme |
-20% |
NoneNone |
NoneNone |
View
|
DNA encoding receptor of vasoactive intestinal polypeptide |
AZAURIDINE |
Vasoactive Intestinal Peptide VIP1 |
-20% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 2b |
KETOROLAC |
Adrenergic alpha2B |
-20% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor 2 |
ETHINYLESTRADIOL |
Leukotriene B4 |
-20% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor |
ETHINYLESTRADIOL |
Leukotriene B4 |
-20% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor |
ETHINYLESTRADIOL |
Leukotriene B4 |
-20% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor 2 |
ETHINYLESTRADIOL |
Leukotriene B4 |
-20% |
NoneNone |
NoneNone |
View
|
protein kinase C, alpha |
BETA-ESTRADIOL |
Protein Serine/Threonine Kinase PKCalpha |
-20% |
NoneNone |
NoneNone |
View
|
protein kinase C, alpha |
BETA-ESTRADIOL |
Protein Serine/Threonine Kinase PKCalpha |
-20% |
NoneNone |
NoneNone |
View
|
DNA encoding receptor of vasoactive intestinal polypeptide |
NOCODAZOLE |
Vasoactive Intestinal Peptide VIP1 |
-20% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor 2 |
BETA-ESTRADIOL |
Leukotriene B4 |
-20% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor |
BETA-ESTRADIOL |
Leukotriene B4 |
-20% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor |
BETA-ESTRADIOL |
Leukotriene B4 |
-20% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor 2 |
BETA-ESTRADIOL |
Leukotriene B4 |
-20% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 3 |
METOPROLOL |
Protein Serine/Threonine Kinase, ERK1 |
-20% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 3 |
METOPROLOL |
Protein Serine/Threonine Kinase, ERK1 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 |
AJMALINE |
Cyclooxygenase COX-2 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
AJMALINE |
Cyclooxygenase COX-2 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
ETHINYLESTRADIOL |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
ETHINYLESTRADIOL |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
AZAURIDINE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
AZAURIDINE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
arginine vasopressin receptor 1A |
KETOROLAC |
Vasopressin V1A |
-20% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, beta 1 |
PHENOBARBITAL |
Adrenergic beta1 |
-20% |
NoneNone |
NoneNone |
View
|
adrenergic, beta-1-, receptor |
PHENOBARBITAL |
Adrenergic beta1 |
-20% |
NoneNone |
NoneNone |
View
|
neuropeptide Y receptor Y1 |
PHENOBARBITAL |
Neuropeptide Y1 |
-20% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 5B |
PHENOBARBITAL |
Serotonin 5-HT4 |
-20% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 4 |
PHENOBARBITAL |
Serotonin 5-HT4 |
-20% |
NoneNone |
NoneNone |
View
|
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
AFLATOXIN B1 |
CYP450-2C9 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
cytochrome P450, family 2, subfamily C, polypeptide 9 |
AFLATOXIN B1 |
CYP450-2C9 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 |
AFLATOXIN B1 |
Cyclooxygenase COX-2 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
AFLATOXIN B1 |
Cyclooxygenase COX-2 |
-20% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, AMPA1 (alpha 1) |
LIPOPOLYSACCHARIDE E. COLI O55:B5 |
Glutamate, AMPA |
-20% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, AMPA2 |
LIPOPOLYSACCHARIDE E. COLI O55:B5 |
Glutamate, AMPA |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type II, beta |
D-CAMPHOR |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type II, alpha 2 |
D-CAMPHOR |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type I, beta |
D-CAMPHOR |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type I, alpha |
D-CAMPHOR |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
FLUPHENAZINE |
Potassium Channel [KATP] |
-20% |
NoneNone |
NoneNone |
View
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 9 |
FLUPHENAZINE |
Potassium Channel [KATP] |
-20% |
NoneNone |
NoneNone |
View
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
FLUPHENAZINE |
Potassium Channel [KATP] |
-20% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, beta 1 |
D-CAMPHOR |
Adrenergic beta1 |
-20% |
NoneNone |
NoneNone |
View
|
adrenergic, beta-1-, receptor |
D-CAMPHOR |
Adrenergic beta1 |
-20% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 14 |
FLUPHENAZINE |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 14 |
FLUPHENAZINE |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-1A2 monooxygenase |
METHYLPARABEN |
CYP450-1A2 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 5 |
D-CAMPHOR |
Muscarinic M5 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IV, beta |
D-CAMPHOR |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel associated protein 1 |
D-CAMPHOR |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel associated protein 2 |
D-CAMPHOR |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
cannabinoid receptor 1 (brain) |
DEXTROMETHORPHAN |
Cannabinoid CB1 |
-20% |
NoneNone |
NoneNone |
View
|
3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
CAFFEIC ACID PHENETHYL ESTER |
HMG-CoA Reductase |
-20% |
NoneNone |
NoneNone |
View
|
3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
CAFFEIC ACID PHENETHYL ESTER |
HMG-CoA Reductase |
-20% |
NoneNone |
NoneNone |
View
|
interleukin 8 receptor, beta |
CAFFEIC ACID PHENETHYL ESTER |
Chemokine CXCR2 (IL-8B) |
-20% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, AMPA3 (alpha 3) |
THIMEROSAL |
Glutamate, AMPA |
-20% |
NoneNone |
NoneNone |
View
|
glutamate receptor subunit 4c |
THIMEROSAL |
Glutamate, AMPA |
-20% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 2C |
DESOXIMETASONE |
Serotonin 5-HT2C |
-20% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, beta 1 |
GALANTAMINE |
Adrenergic beta1 |
-20% |
NoneNone |
NoneNone |
View
|
adrenergic, beta-1-, receptor |
GALANTAMINE |
Adrenergic beta1 |
-20% |
NoneNone |
NoneNone |
View
|
neuropeptide Y receptor Y2 |
BUTAMBEN |
Neuropeptide Y2 |
-20% |
NoneNone |
NoneNone |
View
|
neuropeptide Y receptor Y2 |
BUTAMBEN |
Neuropeptide Y2 |
-20% |
NoneNone |
NoneNone |
View
|
natriuretic peptide receptor 2 |
THIMEROSAL |
Atrial Natriuretic Factor (ANF) |
-20% |
NoneNone |
NoneNone |
View
|
guanylate cyclase A/atrial natriuretic peptide receptor (Non-specific probe) |
THIMEROSAL |
Atrial Natriuretic Factor (ANF) |
-20% |
NoneNone |
NoneNone |
View
|
natriuretic peptide receptor 3 |
THIMEROSAL |
Atrial Natriuretic Factor (ANF) |
-20% |
NoneNone |
NoneNone |
View
|
adenosine A1 receptor |
BENZOTHIAZYL DISULFIDE |
Adenosine A1 |
-20% |
NoneNone |
NoneNone |
View
|
protein kinase C, alpha |
TIMOLOL |
Protein Serine/Threonine Kinase PKCalpha |
-20% |
NoneNone |
NoneNone |
View
|
protein kinase C, alpha |
TIMOLOL |
Protein Serine/Threonine Kinase PKCalpha |
-20% |
NoneNone |
NoneNone |
View
|
calcitonin receptor |
CROTAMITON |
Calcitonin |
-20% |
NoneNone |
NoneNone |
View
|
matrix metalloproteinase 1 (interstitial collagenase) |
THIMEROSAL |
Protease, Matrix Metalloprotease-1 (MMP-1) |
-20% |
NoneNone |
NoneNone |
View
|
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
DIPYRIDAMOLE |
Serotonin Transporter |
-20% |
NoneNone |
NoneNone |
View
|
Protein-tyrosine kinase, Fyn |
BENZBROMARONE |
Protein Tyrosine Kinase, Fyn |
-20% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 2 |
BENZBROMARONE |
Muscarinic M2 |
-20% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase 5a, mitochondrial |
THIOGUANINE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase 3 |
THIOGUANINE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase 2 |
THIOGUANINE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase 4 |
THIOGUANINE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase XI |
THIOGUANINE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase IX |
THIOGUANINE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase VIII |
THIOGUANINE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase VII |
THIOGUANINE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase VA, mitochondrial |
THIOGUANINE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase IV |
THIOGUANINE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase III, muscle specific |
THIOGUANINE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase I |
THIOGUANINE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase XIV |
THIOGUANINE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase VB, mitochondrial |
THIOGUANINE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase XII |
THIOGUANINE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase VI |
THIOGUANINE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase II |
THIOGUANINE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
matrix metallopeptidase 9 |
FLUNISOLIDE |
Protease, Matrix Metalloprotease-9 (MMP-9) |
-20% |
NoneNone |
NoneNone |
View
|
matrix metalloproteinase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
FLUNISOLIDE |
Protease, Matrix Metalloprotease-9 (MMP-9) |
-20% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-1A2 monooxygenase |
MEGESTROL ACETATE |
CYP450-1A2 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
DIPYRIDAMOLE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
thromboxane A synthase 1 |
DIPYRIDAMOLE |
Thromboxane Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) |
DIPYRIDAMOLE |
Thromboxane Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
CIMETIDINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
CIMETIDINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
CIMETIDINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
CIMETIDINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
CIMETIDINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
CIMETIDINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
CIMETIDINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
CIMETIDINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|